Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy.
Marco A ZarbinLauren HillAndreas MaunzMartin GliemIvaylo StoilovPublished in: The British journal of ophthalmology (2021)
TR-SRF was not detrimental to vision outcomes over 2 years, regardless of thickness. MA rates were significantly higher without TR-SRF.